Printivo is at the forefront of biomedical innovation, specializing in 3D bioprinting technologies aimed at advancing human health. The company focuses on creating bioprinted human bone tissue, which is utilized for in-vitro efficacy and toxicity assays. This technology allows Printivo to provide pharmaceutical companies with on-demand bone tissue grafts that can be employed in pre-clinical drug testing, offering a more accurate alternative to traditional animal models. By developing a bone tissue model that closely mimics the dimensional complexity and cellular interactions of native human tissue, Printivo enhances the reliability of data regarding the effects of new drug molecules.

Central to Printivo's operations is their proprietary 3D-bioprinting pneumatic extrusion technology, embodied in their bioprinter named EVE. This system is designed to work in synergy with their bioink formulations, known as ADAM, which are crafted to sustain cellular life. The bioinks primarily consist of collagen, supplemented with various synthetic and natural polymers, enabling the creation of tissue constructs with optimized microarchitecture. Printivo's commitment to tissue engineering extends to working with stem cells, allowing them to differentiate these cells to a mature state for further examination of protein production and activity. Through these advanced technologies, Printivo aims to revolutionize drug development and ultimately contribute to the creation of fully functional 3D-bioprinted human organs.

Bulgaria

Printivo is startup company  operating in the field of Biotechnology. Currently we are situated in Sofia, Bulgaria.

Our motto – “We print life” is the quintessence of our main goal namely to fabricate and design native-like human tissues and organs. Our inspiration is driven by the huge necessity of finding solutions for the growing humanitarian problem with shortage of organ transplants. Hundreds of people die each day, in this very minute in fact, failing to receive organ transplantation. This life-giving act must be accessible and affordable to each person and we are ready to take this difficult, uncertain and long way to fulfill their needs. 

Printivo

Company Details